Schonfeld Strategic Advisors LLC Haemonetics Corp Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 10,427 shares of HAE stock, worth $776,498. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,427
Previous 56,399
81.51%
Holding current value
$776,498
Previous $4.81 Million
82.09%
% of portfolio
0.01%
Previous 0.03%
Shares
24 transactions
Others Institutions Holding HAE
# of Institutions
337Shares Held
55.5MCall Options Held
383KPut Options Held
45.1K-
Capital Research Global Investors Los Angeles, CA6.92MShares$515 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$444 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$383 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$286 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY3.83MShares$286 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.82B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...